Zavaleta-Muñiz S A, Martín-Márquez B T, Gonzalez-Lopez L, Gonzalez-Montoya N G, Díaz-Toscano M L, Ponce-Guarneros J M, Ruiz-Padilla A J, Vázquez-Del Mercado M, Maldonado-González M, Fafutis-Morris M, Flores-Martínez S E, Martínez-García E A, Gamez-Nava J I
Unidad de Investigación en Epidemiología Clínica, Centro Médico Nacional de Occidente, Instituto Mexicano del Seguro Social (IMSS), Hospital de Especialidades, 44340 Guadalajara, Mexico ; Doctorado en Ciencias Biomédicas, Orientación en Inmunología, Centro Universitario de Ciencias de la Salud (CUCS), Universidad de Guadalajara, 44340 Guadalajara, Mexico.
Clin Dev Immunol. 2013;2013:959084. doi: 10.1155/2013/959084. Epub 2013 Sep 23.
There is a lack of information about the genotype frequencies of IL-6 -174G/C and -572G/C polymorphisms in Mexicans with rheumatoid arthritis (RA). Therefore, the aim of this study was to evaluate the association of the IL-6 -174G/C and -572G/C polymorphisms in Mexican mestizo with RA.
We included 137 patients with RA and 102 healthy controls. Patients were assessed for clinical characteristics. IL-6 -174G/C and -572G/C polymorphisms were genotyped using PCR-RFLP analysis. Allele and genotype frequencies and the Hardy-Weinberg equilibrium were computed. Odds ratios (ORs) were computed to identify the risk for RA associated with the presence of GG genotype in comparison with the GC or CC genotypes.
The genotype -174GG occurred at a higher frequency in cases and controls (77.4% versus 78.4%, P = 0.845). We found similar results for the genotype -572GG (54% in patients versus 60.8% in controls, P = 0.295).
This is the first study to evaluate the association of -174G/C and -572G/C polymorphisms of the IL-6 gene with RA in Mexican mestizo patients. These two polymorphisms were not associated with RA in the studied sample. Additional studies are required to evaluate if these IL-6 polymorphisms have relevance to the development of more severe disease.
关于类风湿关节炎(RA)墨西哥患者白细胞介素-6(IL-6)-174G/C和-572G/C多态性的基因型频率,目前缺乏相关信息。因此,本研究的目的是评估墨西哥混血人种中IL-6 -174G/C和-572G/C多态性与RA的相关性。
我们纳入了137例RA患者和102例健康对照。对患者的临床特征进行评估。采用聚合酶链反应-限制性片段长度多态性分析(PCR-RFLP)对IL-6 -174G/C和-572G/C多态性进行基因分型。计算等位基因和基因型频率以及哈迪-温伯格平衡。计算比值比(OR)以确定与GC或CC基因型相比,GG基因型的存在与RA相关的风险。
-174GG基因型在病例组和对照组中的出现频率较高(分别为77.4%和78.4%,P = 0.845)。-572GG基因型的结果相似(患者中为54%,对照组中为60.8%,P = 0.295)。
这是第一项评估墨西哥混血人种患者中IL-6基因-174G/C和-572G/C多态性与RA相关性的研究。在研究样本中,这两种多态性与RA无关。需要进一步研究以评估这些IL-6多态性是否与更严重疾病的发生有关。